BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Prognosis
34 results:

  • 1. Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC.
    Xue W; Jian W; Meng Y; Wang T; Cai L; Yu Y; Yu Y; Xia Z; Zhang C
    Cell Death Dis; 2023 Aug; 14(8):539. PubMed ID: 37604811
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation.
    Javaid H; Barberis A; Chervova O; Nassiri I; Voloshin V; Sato Y; Ogawa S; Fairfax B; Buffa F; Humphrey TC
    BMC Cancer; 2023 Aug; 23(1):721. PubMed ID: 37528416
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis.
    Lee JH; Kim YJ; Ryu HW; Shin SW; Kim EJ; Shin SH; Park JY; Kim SY; Hwang CS; Na JY; Shin DH; Kim JY; Lee HJ
    Diagn Pathol; 2023 Mar; 18(1):36. PubMed ID: 36894965
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic value of Talin-1 in renal cell carcinoma and its association with B7-H3.
    Saeednejad Zanjani L; Vafaei S; Abolhasani M; Fattahi F; Madjd Z
    Cancer Biomark; 2022; 35(3):269-292. PubMed ID: 36245369
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating HMGA2 Transcription through KDM2A-mediated H3K36me2 Demethylation.
    Lin J; Chen X; Yu H; Min S; Chen Y; Li Z; Xie X
    Int J Biol Sci; 2022; 18(9):3621-3635. PubMed ID: 35813477
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Fibronectin enhances tumor metastasis through B7-H3 in clear cell renal cell carcinoma.
    Xie J; Sun M; Zhang D; Chen C; Lin S; Zhang G
    FEBS Open Bio; 2021 Nov; 11(11):2977-2987. PubMed ID: 34431237
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The presence of tumour-infiltrating neutrophils is an independent adverse prognostic feature in clear cell renal cell carcinoma.
    Tessier-Cloutier B; Twa DD; Marzban M; Kalina J; Chun HE; Pavey N; Tanweer Z; Katz RL; Lum JJ; Salina D
    J Pathol Clin Res; 2021 Jul; 7(4):385-396. PubMed ID: 33665979
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Axcrona U; Abolhasani M; Rasti A; Asgari M; Fodstad Ø; Andersson Y
    Ann Diagn Pathol; 2020 Jun; 46():151483. PubMed ID: 32143173
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12.
    González-Rodríguez P; Engskog-Vlachos P; Zhang H; Murgoci AN; Zerdes I; Joseph B
    Cell Death Dis; 2020 Jan; 11(1):69. PubMed ID: 31988284
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
    Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
    Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma.
    Azuma T; Sato Y; Ohno T; Azuma M; Kume H
    PLoS One; 2018; 13(7):e0199719. PubMed ID: 30044793
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Relationship and Predictive Role of the Dual Expression of FGFR and IL-8 in Metastatic Renal Cell Carcinoma Treated with Targeted Agents.
    Iacovelli R; DE Tursi M; Mosillo C; Ciardi A; Carella C; Natoli C; Naso G; Cortesi E
    Anticancer Res; 2018 May; 38(5):3105-3110. PubMed ID: 29715147
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Histone H3 Lysine 4 Trimethylation, Lysine 27 Trimethylation, and Lysine 27 Acetylation Contribute to the Transcriptional Repression of Solute Carrier Family 47 Member 2 in Renal Cell Carcinoma.
    Yu Q; Liu Y; Zheng X; Zhu Q; Shen Z; Wang H; He H; Lin N; Jiang H; Yu L; Zeng S
    Drug Metab Dispos; 2017 Jan; 45(1):109-117. PubMed ID: 27821436
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma.
    Qu Y; Liu L; Wang J; Xi W; Xia Y; Bai Q; Xiong Y; Long Q; Xu J; Guo J
    Oncotarget; 2016 Dec; 7(51):84775-84784. PubMed ID: 27713173
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
    Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
    Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. FGF23: mediator of poor prognosis in a sizeable subgroup of patients with castration-resistant prostate cancer presenting with severe hypophosphatemia?
    Lee EK; Martinez MC; Blakely K; Santos KD; Hoang VC; Chow A; Emmenegger U
    Med Hypotheses; 2014 Oct; 83(4):482-7. PubMed ID: 25155552
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma.
    Masuda A; Arai K; Nishihara D; Mizuno T; Yuki H; Kambara T; Betsunoh H; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T
    Biomed Res Int; 2014; 2014():396064. PubMed ID: 25089268
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma.
    Lebdai S; Verhoest G; Parikh H; Jacquet SF; Bensalah K; Chautard D; Rioux Leclercq N; Azzouzi AR; Bigot P
    Urol Oncol; 2015 Feb; 33(2):69.e11-8. PubMed ID: 25035170
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.
    Quandt D; Jasinski-Bergner S; Müller U; Schulze B; Seliger B
    J Transl Med; 2014 May; 12():151. PubMed ID: 24885059
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.